ライフサイエンスコーパス: the risk of

1 In a post hoc analysis, we compared the risk of 3 composite bleeding outcomes and 3 composit

2 ion, or post-injection medication, increased the risk of a complication.

3 BCG vaccination reduced the risk of a positive baseline IGRA (relative risk [RR]

4 Tocilizumab significantly reduced the risk of a subsequent NMOSD relapse compared with aza

5 outine childhood immunisation in Africa with the risk of acquiring severe acute respiratory syndrome

6 hold crowding, low income) probably increase the risk of acquisition of an exogenous nonprimary CMV i

7 This study aimed to investigate the risk of acute kidney injury (AKI) in hospitalized pa

8 The risk of acute kidney injury was lower between those

9 We observed no differences in the risk of acute MI, CVD, major bleeding, or all-cause

10 st that ATG, as compared to IL2RA, may lower the risk of acute rejection without increasing hepatic c

11 d use is prevalent in asthma management, and the risks of acute and chronic complications increase wi

12 n debt with prescribed fire will help reduce the risk of additional mortality from wildfire, but at a

13 not bind to the virion, thereby eliminating the risk of ADE.

14 ere are few observational studies evaluating the risk of AKI in people with type 2 diabetes, and even

15 In the quantitative analysis, the risk of allergic diseases decreased significantly wi

16 pressed on Myeloid cells 2 (TREM2) increases the risk of Alzheimer's disease (AD).

17 odulated by neuroinflammation via IFITM3 and the risk of Alzheimer's disease is thereby increased.

18 The risk of an elevated viral load (>=400 copies/mL) was

19 the allergen at the injection site to reduce the risk of anaphylaxis.

20 The purpose of this study was to define the risk of, and associations with, SAE and high-dose ra

21 It is uncertain if the risk of aortic dilation of varying degrees aggregate

22 interact with each other to jointly predict the risk of asthma - which suggests the pivotal role of

23 changes in the infant microbiota may elevate the risk of asthma and atopic traits, probably via cross

24 (DNAm) has been shown to be associated with the risk of asthma.

25 Both type 1 and type 2 diabetes increase the risk of atherosclerotic cardiovascular disease (CVD)

26 , CHIP is also associated with a doubling of the risk of atherosclerotic cardiovascular disease.

27 The risk of atypical femur fracture increased with longe

28 tic, or synthetic therapeutics that decrease the risk of autoimmune, metabolic, neoplastic, and infec

29 ize of 108,416, MetS significantly increased the risk of BE (OR = 1.354; 95% CI: 1.145-1.600; P < 0.0

30 spontaneous cerebellar ICH are lacking, and the risk of bias in published series is high.

31 interest policies and procedures to minimize the risk of bias or improper influence during developmen

32 Despite the risk of bias, almost all types of intervention seeme

33 adapted the Newcastle-Ottawa Scale to assess the risk of bias.

34 of the causal role of markers by minimizing the risk of biases such as reverse causation and confoun

35 III activity does not seem to correlate with the risk of bleeding as suggested from previous studies.

36 nly achieving FVIII activity >=50% abolished the risk of bleeding.

37 of death, MI, and stroke without increasing the risk of bleeding.

38 , exogenous antithrombin itself may increase the risk of bleeding.

39 lable features that can potentially increase the risk of both bleeding and thrombosis.

40 actions that have strong potential to reduce the risk of both undernutrition, obesity, and DR-NCDs.

41 olecular biomarkers causally associated with the risk of CAD within genomic regions known to be assoc

42 Given the limited data regarding the risk of cancer recurrence in transplant recipients,

43 bosis remained independently associated with the risk of carcinoma (odds ratio, 1.97; 95% confidence

44 fit over the pharmaco-invasive strategy, and the risk of cardiac catheterization laboratory provider

45 s may synergistically contribute to modulate the risk of cardiometabolic and other non-communicable d

46 No significant difference in the risk of cardiovascular death was observed for patien

47 than total carbohydrate intake may determine the risk of cardiovascular disease (CVD).

48 Ageing and inflammation strongly drive the risk of cardiovascular disease.

49 ugs, and aspirin has been proposed to reduce the risk of cardiovascular disease.

50 salicylic acid (aspirin; ASA) 100 mg reduced the risk of cardiovascular events as compared with ASA m

51 medical therapies aimed at further reducing the risks of cardiovascular events in patients with chro

52 0.83; 95% CI: 0.77-0.89; P < 0.001) to lower the risk of CHD, but these effect estimates attenuated s

53 educed-fat milk for children might not lower the risk of childhood obesity.

54 ween sex-specific quintiles of DF intake and the risk of chronic diseases and mortality were assessed

55 Each additional metabolic trait increased the risk of cirrhosis and HCC in patients with NAFLD.

56 For each TA-allele, the risk of cirrhosis and hepatocellular carcinoma was r

57 The risk of clinical relapse and hepatic decompensation

58 Even though the risk of clonal progression or a cardiovascular event

59 g-term outcomes are generally good; however, the risk of complications still exists despite transplan

60 s rate of orotracheal intubation and reduces the risk of complications when compared with direct lary

61 the TLR10/1/6 locus appear to be linked with the risk of contracting a bloodstream infection.

62 standing of the clusters; it also underlined the risk of covert plasmid propagation in healthcare set

63 No data is available on the risk of COVID-19 and its outcomes in celiac disease

64 The risk of COVID-19 was increased in older patients (p

65 ns between asthma and corticosteroid use and the risk of COVID-19-related hospitalization.

66 , although we need the information regarding the risk of CRC in those patients not referred to colono

67 Also, in women, the risk of CRC with the serrated pathway features was m

68 integrated health care setting, we examined the risks of CRC and related death by baseline colonosco

69 investigate the association between pAF and the risk of CVA.

70 intaining COC should be emphasized to reduce the risk of CVD among hypertension patients.

71 ong-term benefits of PUFA intake in lowering the risk of CVD and premature death.

72 ciation between plasma kallikrein levels and the risk of CVD.

73 1) levels were independently associated with the risk of CVDEs.

74 ssociation between influenza vaccination and the risk of CVDs.

75 the use of direct-acting antivirals (DAA) on the risk of death and tumoral recurrence in patients wit

76 Dapagliflozin reduced the risk of death and worsening heart failure and improv

77 The risk of death decreased by 17% per 1,000-MBq increas

78 uman immunodeficiency virus (HIV) may affect the risk of death due to cardiovascular disease (CVD) di

79 her statin use and/or dyslipidemia increases the risk of DED.

80 hylactic hemoclip placement did not decrease the risk of delayed PPB.

81 The risk of depression according to perceived neighborho

82 munity level were positively associated with the risk of depression among women.

83 r deficits in reward processing may mitigate the risk of depression in nondepressed older adults, esp

84 The primary outcomes were the risk of depression or clinically relevant depressive

85 icipants in the highest aMED score category, the risk of developing a kidney stone was between 13% an

86 The risk of developing active TB within 2 and 5 years we

87 This study aimed to determine whether the risk of developing AD/PD increases after having tinn

88 he presence of comorbidities may also affect the risk of developing adverse events with TKIs.

89 cate that functional ANG appears to decrease the risk of developing ALS but exacerbate ALS once in pr

90 smoking, and genetic predisposition increase the risk of developing GERD.

91 irus (HBV), which can substantially increase the risk of developing liver disease.

92 ging, and in so doing potentially increasing the risk of developing psychiatric disorders.

93 l or no ILM peel) between 2008 and 2016, and the risk of developing retinal detachment within 1 year

94 DM increases the risk of developing TB and contributes to adverse TB

95 ever, there are no contemporary estimates of the risk of developing tuberculosis in exposed children.

96 flammatory potential was not associated with the risk of developing UC (P(trend) = .62).

97 Radiotherapy increased the risk of diabetes but not incident CVD.

98 dium-glucose co-transporter-2 inhibitors and the risk of diabetic ketoacidosis in patients with type

99 erall survival outcomes than adding placebo; the risks of diarrhea and elevated aminotransferase leve

100 As applied today, algorithms can increase the risk of discrimination.

101 The risk of disease progression decreased by 13% per 1,0

102 Physicians should be aware of the risk of dry eye after ptosis surgery and discuss dry

103 lung cancer at an early stage and can reduce the risk of dying from lung cancer.

104 y, a history of statin or SSRI usage reduced the risk of EAC or HGD by 49% or 61%, respectively.

105 ly during multiple time points and also with the risks of eczema and sensitization.

106 Systemic comorbidities that increased the risk of EE in candidemia included endocarditis, cirr

107 ACNS0333 therapy significantly reduced the risk of EFS events in patients < 36 months of age co

108 lects endothelial dysfunction, and increases the risk of end-organ damage.

109 ing the idea that DNA methylation may modify the risk of environmental factors on health outcomes.

110 s interaction with poor oral health elevated the risk of ESCC in a high-risk region of China.

111 ped up to achieve symptom control and reduce the risk of exacerbations and stepped down after a perio

112 milarly, while shaded dry environments lower the risk of exceeding T(opt) , critical EWL limits are s

113 a degree of prosociality is possible despite the risks of exploitation.

114 nd cardiovascular disease (CVD) may increase the risk of fatty liver disease and other metabolic diso

115 research but their use can be limited due to the risk of fibroblast overgrowth.

116 antitative food frequency questionnaire, and the risk of four common cancers (lung, prostate, breast,

117 umed at 1-3 years of age was associated with the risk of fracture between 3 and 10 years of age.

118 Non-pharmacological interventions to manage the risk of fracture should be prescribed to all patient

119 Furthermore, presenting the risks of FT significantly altered the decision makin

120 ns reduced wood hygroscopicity, which limits the risk of further dimensional changes of wood exposed

121 n for treatment of colon cancer may increase the risk of further metastasis.

122 ICS) is controversial, because it can reduce the risk of future exacerbations of the disease at the e

123 The risks of GI cancers combined, esophageal cancer, and

124 r age was associated with a 0.9% increase in the risk of graft loss (hazard ratio [HR], 1.009; P < 0.

125 There was no significant difference in the risks of graft failure (adjusted hazard ratio [aHR]

126 After the first year, the risk of Guillain-Barre was not increased.

127 tery tools which imply limited precision and the risk of harm through collateral thermal damage to th

128 As a result, the risk of harmful non-native marine species being intr

129 the association between UPF consumption and the risk of having short telomeres in an elderly populat

130 We investigated the risk of having thoracic and abdominal aortic sizes i

131 ther with IFN or NUCs, substantially reduces the risk of HCC development, even if antiviral therapy f

132 SVR reduced the risk of HCC.

133 um-glucose cotransporter 2 inhibitors reduce the risk of heart failure hospitalization and cardiovasc

134 le in blood pressure regulation and reducing the risk of heart failure.

135 al-hazards regression modeling, we estimated the risk of hepatocellular carcinoma and liver-related m

136 In the most adjusted Cox models, the risk of HF was 39% and 62% lower among moderate fit

137 e oncogenic capability of HPV16 and increase the risk of HGAIN in people with HIV.

138 ined very low as compared with reductions in the risk of hip and other fractures with bisphosphonate

139 We sought to assess the risk of HL associated with allergic disease (asthma,

140 ine the association between polypharmacy and the risk of hospitalization and mortality.

141 increase patient compliance while mitigating the risk of hypoglycemia.

142 ; 95% CI, 1.01-1.02) increased significantly the risk of ICU admission.

143 ogistic regression analysis, we investigated the risk of IE according to streptococcal species adjust

144 CI} .83-.97]; P = .01), and strongly reduced the risk of IGRA conversion (RR, 0.56 [95% CI, .40-.77];

145 Aggregates increase the risk of immune responses in patients and therefore m

146 Orthopedic surgeons are concerned with the risk of implant infections following a dental proced

147 in China and directed to Africa to estimate the risk of importation per country.

148 The risk of incarceration during nonoperative management

149 The aim of the study was to quantify the risk of incarceration of incisional hernias.

150 Our results also highlight the risks of increasing bottled water use in rural areas

151 To quantify the risk of individual misidentification and its impact

152 pies and radiotherapy boost did not increase the risk of induration.

153 The risk of infection and transmission may be driven by

154 FNA for pancreatic cyst evaluation, we found the risk of infection to be low.

155 r the Duffy-null genotype is associated with the risk of infection using the UK Biobank sample and th

156 The risk of infection was also higher in children of kid

157 Cox analysis indicated a graded increase in the risk of infection with higher levels of FGF23 (HR, 1

158 r, immune-related adverse events (irAEs) and the risk of infections are not well studied.

159 ing maintenance hemodialysis, might increase the risk of infections.

160 The risk of intracranial progression or death was reduce

161 in mating encounters by moving fast because the risk of isolation is low, and they must compete with

162 Antireflux surgery may decrease the risk of laryngeal squamous cell carcinoma and possib

163 therapeutic windows of opportunity to reduce the risk of late-onset Alzheimer's disease.

164 ate that Ig GM 17/17 genotype contributes to the risk of later AD development, independent of apolipo

165 parameters is potentially useful to stratify the risk of LI after SOT.

166 fter locally resected T1 CRC is dependent on the risk of LNM.

167 ls 12 months after LT significantly impacted the risk of long-term CVE.

168 eficial in the most severe cases by reducing the risk of losing the globe altogether.

169 aging does not confer additional increase in the risk of lung cancer.

170 statistically significantly associated with the risk of lung, breast, colorectal, or prostate cancer

171 The risk of lymph node involvement was calculated using

172 I, 0.45-0.79]), with no increase observed in the risk of MACE (2.73% versus 3.11%; HR, 0.88 [95% CI,

173 mg/dl (IQR: 33.7 to 67.2 mg/dl), and reduced the risk of MACE (hazard ratio [HR]: 0.85; 95% confidenc

174 a P2Y(12) inhibitor has been shown to reduce the risk of major adverse cardiovascular events (MACE) c

175 acotherapies to prevent POAF and to decrease the risk of major adverse events in these high-risk pati

176 to 3 months after PCI significantly reduced the risk of major bleeding by 40% compared with dual ant

177 ng Anticoagulation Strategies) but increased the risk of major bleedings.

178 L cholesterol lowering significantly reduced the risk of major vascular events (n=3519) in older pati

179 Conversely, the risks of major bleeding (RR, 1.36; 95% CI, 0.55-3.35

180 leading to HSC depletion and dysfunction and the risk of malignant transformation over time.

181 suppression of de novo infection may reduce the risk of malignant transformation.

182 polar disorder and concerns about increasing the risk of mania.

183 HMS at the time of cataract surgery lowered the risk of markedly elevated IOP in the early postopera

184 ind that primary infection appears to reduce the risk of medically attended infection with that subty

185 possible causal effects of dietary intake on the risk of metabolic diseases, we performed meta-analys

186 To assess the risk of metabolic syndrome we estimated HRs and 95%

187 No differences were identified for the risk of MI, CVD, major bleeding, or all-cause hospit

188 The risk of miscarriage by ancestry was assessed using m

189 .9% (HR 0.36, 95% CI 0.16, 0.47) decrease in the risk of miscarriage, confirming a strong association

190 The risk of misdiagnosis as more aggressive lymphomas, c

191 imab was compared with all other treatments, the risk of MMP relapse at any site (HR = 0.17, P = .02)

192 Overweight and obesity increase the risk of morbidity and mortality.

193 patients with acute kidney injury (AKI) and the risk of mortality is high, especially if renal repla

194 reviewed epidemiologic studies that assessed the risk of mortality, hospital admissions, and symptoms

195 ical measures of pulmonary insufficiency and the risk of mortality.(C) RSNA, 2019Online supplemental

196 ression in adults to consider information on the risk of neural tube defects in women taking dolutegr

197 has declined in western Kenya, resulting in the risk of neurological phenotypes in older children.

198 However, the risk of obesity was significantly higher in the sub-

199 association between early-life nutrition and the risks of obesity and diabetes.

200 is, making it a potential target to decrease the risks of obesity, type 2 diabetes, and cardiovascula

201 reatment group differences were observed for the risk of operative complications (0.6% vs. 0%, p = 0.

202 s, and cocaine use, select co-usage elevated the risk of oral disease.

203 tions of lipid-related genetic variants with the risk of overall and 22 site-specific cancers for 367

204 ome time for rapid investigation to minimize the risk of overtreatment and antibiotic-associated harm

205 The relationship between smoking amount and the risk of overweight or obesity was U-shaped, and the

206 o ascertain whether PCSK9 inhibition reduces the risk of PAD events or VTE after acute coronary syndr

207 We compared the risk of Parkinson's disease in patients with diabete

208 peptidyl peptidase 4 (DPP4) inhibitors, with the risk of Parkinson's disease of users of any other or

209 e effect of beta-adrenoceptor antagonists on the risk of Parkinson's disease would be small compared

210 ous genes whose mutations cause, or increase the risk of, Parkinson's disease (PD) have been identifi

211 The risk of patient-oriented composite end point was com

212 is large, population-based, family database, the risk of PC varied by cancer FH and was most strongly

213 pothesized that the use of statins may lower the risk of PEP.

214 The risk of perinatal death and severe neonatal morbidit

215 d postoperative strategies aimed at reducing the risk of perioperative stroke and at improving the ou

216 circulating eosinophils, ICS treatment, and the risk of pneumonia in patients with COPD.Methods: Thi

217 of the disease at the expense of increasing the risk of pneumonia.Objectives: To assess the relation

218 SC-TNT does not significantly increase the risk of POM compared to CRT.

219 The risk of poor body weight gain increased in FPIES tri

220 ions between stressors vastly underestimates the risk of population crashes.

221 UTRs in neuronal development and underscore the risk of post-transcriptional dysregulation in co-occ

222 The risk of postoperative constipation was higher with P

223 Better awareness of the risk of posttransplant KS for recipients of organs f

224 or an external carotid approach to minimize the risk of potentially vision-threatening choroidal com

225 Approaches to Stop Hypertension (DASH) with the risk of pre-eclampsia and GHTN.

226 of spatiotemporal response by female elk to the risk of predation posed by wolves in northern Yellow

227 Shallow invasion increases the risk of pregnancy complications, e.g., severe preecl

228 ves maternal oral health but fails to reduce the risk of preterm birth.

229 Evaluating the risk of progression using naive CD4+ T-cells was pre

230 PSA in its free and bound forms to enumerate the risk of prostate cancer and has found acceptance wit

231 hat the use of 3-piece IOL models may reduce the risk of pseudophakic VAO in children younger than 2

232 xposure to environmental toxins can increase the risk of PSP.

233 ined whether FA supplementation could reduce the risk of PTD associated with maternal exposure to PM

234 on >= 3 months prior to pregnancy may lessen the risk of PTD associated with PM exposure during pregn

235 lation produces large enough lesions without the risk of PV stenosis, artery, nerve, or esophageal da

236 mics data can be used to effectively predict the risk of RA and identify cases in early stages to pre

237 The risk of rabies in a biting dog as assessed through H

238 c regression model was developed to quantify the risk of rabies in biting dogs, using data from Haiti

239 reatment of TB and HIV to potentially reduce the risk of reactivation of TB due to HIV to inform trea

240 To reduce the risk of recurrence, patients should consume a high-q

241 s) for breast cancer is common and increases the risk of recurrence.

242 prove the detection of tumors and can reduce the risk of recurrence.

243 gnancy after breast cancer does not increase the risk of recurrence; however, very limited data are a

244 The risk of recurrent colonic adenoma associated with hi

245 e primary analysis comprising 2607 patients, the risk of recurrent VTE was nonsignificantly lower wit

246 elated hospitalization and 3 later points to the risk of recurrent wheezing by age 3 years.

247 argeting the interleukin-6 receptor, reduced the risk of relapse in patients with neuromyelitis optic

248 Adjuvant dabrafenib plus trametinib reduced the risk of relapse versus placebo in patients with rese

249 f asparaginase treatment intensity increases the risk of relapse.

250 or in combination with vitamin D may reduce the risk of SCC, but not BCC.

251 ubgroup analysis among symptomatic patients, the risk of SCD was increased in highly active and inact

252 that prenatal immune challenges may elevate the risk of schizophrenia and related psychoses in offsp

253 The risk of SCI in pancreas transplantation was estimate

254 The aim of this study was to quantify the risk of SCI in pancreatic transplantation.

255 DF intake from fruit was associated with the risk of several chronic diseases.

256 strong evidence that smoking also increases the risk of several other cancers.

257 In addition, the risk of several SLE related ophthalmic disorders, in

258 ptibility to SARS-CoV-2 infection but reduce the risk of severe COVID-19.

259 Metabolic syndrome increases the risk of severe disease due to viral infection.

260 Globally, the risk of severe outcomes associated with COVID-19 has

261 ettings, seroconversion dramatically reduced the risk of severe rotavirus gastroenteritis (HR, 0.46;

262 The risk of severe RSV-ALRI (odds ratio, 2.2; 95% confid

263 [KIAA1755]); heart rate (rgs6 and hcn4); and the risk of sinoatrial pauses and arrests (hcn4).

264 ied to footwear outsoles could help mitigate the risk of slips and falls in a range of environments.

265 ife exposure to inhalant allergens increases the risk of specific sensitization and whether FLG mutat

266 nother related, but less studied concern, is the risk of 'spillback' transmission from humans into no

267 Genetic factors likely influence the risk of spread.

268 red to usual care, PSM significantly reduced the risk of stroke (risk ratio [RR] 0.24, 95% CI 0.08-0.

269 tients who have survived an AMI would reduce the risk of subsequent cardiovascular events during 2 ye

270 tory syndrome coronavirus 2 (SARS-CoV-2) and the risk of subsequent reinfection remains unclear.

271 for software developers and users to reduce the risk of such errors.

272 use (HR = 2.28, 95%CI 1.08-4.80), increased the risk of suicide.

273 IPT reduced the risk of TB by approximately 30% (aHR, 0.71 [95% CI,

274 The risk of the composite of recurrent VTE or major blee

275 ng intravenous or endovascular thrombolysis, the risk of the composite of stroke or death within 30 d

276 in a combined cocktail (REGN-COV2) to reduce the risk of the emergence of treatment-resistant mutant

277 that PCOS in and of itself does not increase the risk of these outcomes.

278 The risks of these local regrowths have not yet been ful

279 other hand, a prothrombotic state increases the risk of thromboembolic disease through the activatio

280 ts into how CHRNA3 risk alleles can increase the risk of tobacco dependence and smoking-related disea

281 y period of proteasome inhibition and reduce the risk of toxicity from long-term treatment.

282 rapidly improve clinical outcome and reduce the risk of toxicity.

283 ress, and possibly inflammation may increase the risk of transformation from CH to a myeloid malignan

284 we critically examine the available data on the risk of transmission of SARS-CoV-2 through organ tra

285 une systems of pigs and humans as well as by the risk of transmitting porcine endogenous retroviruses

286 What are the risks of treating the patient for the health care te

287 rug-resistant gastrointestinal pathogens and the risk of treatment failures.

288 The risk of type B aortic dissection is close to the rem

289 al structure in pharmaceuticals and minimize the risk of unanticipated late-appearing polymorphs.

290 s with Covid-19, no significant reduction of the risk of unfavorable outcomes was observed with hydro

291 y early reversal of ischemia, and decreasing the risk of unintentional surgical damage.

292 basis for antibiotic prescription; however, the risks of unwarranted antibiotics and lack of guideli

293 However, the risk of vancomycin-resistant enterococcal infection

294 The risk of vertical transmission can be reduced by earl

295 Preliminary evidence suggests that the risk of violence was higher for persistent heavy use

296 to both patient care, and the mitigation of the risk of viral transmission during surgery, provided

297 rtase subtilisin/kexin type 9) inhibition on the risk of VTE, explore potential mechanisms, and exami

298 on sex and birth year were used to estimate the risk of XFS in patients with OSA.

299 Viral shedding in the semen can increase the risk of ZIKV transmission through sexual mode.

300 mination at human-swine interfaces to reduce the risk of zoonotic infections and to inform pandemic p